Quality of life improvements in patients with PsA who achieve remission or low disease activity targets: results from two clinical trials of ixekizumab at three years of treatment
| Egile Nagusiak: | , , , , , , |
|---|---|
| Formatua: | Conference item |
| Hizkuntza: | English |
| Argitaratua: |
Oxford University Press
2021
|
| Gaia: |
|---|